Healthcare providers should communicate clearly about common signs such as heavy, prolonged, or painful menstrual bleeding, pelvic pressure, urinary difficulties, and lower back pain
If you are interested in broader peptide topics beyond GLP-1 agonists, peptide safety and risks provides important context
Beginning with the lowest dose allows you and your doctor to understand how the treatment affects you, including changes in appetite and potential side effects
Eli Lilly confirmed that manufacturing capacity could meet demand for both Mounjaro and Zepbound across all dose strengths
That may or may not see the light of the day from the political side of it, but we cant ignore that, he said
Furthermore, the fat pads in the face can shrink, and even the underlying facial skeleton may experience some reduction in volume, further diminishing internal support and contributing to the overall sagging effect